Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
126.62
+0.31 (0.25%)
At close: Dec 4, 2025
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $255.15 billion as of December 5, 2025. Its market cap has increased by 23.69% in one year.
Market Cap
255.15B
Enterprise Value
277.71B
Revenue
56.37B
Ranking
n/a
PE Ratio
17.73
Stock Price
$126.62
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 255.15B, an increase of 100.36%. That is a compound annual growth rate of 2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 255.15B | 30.50% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | 215.32B | 0.17% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 569.32M |
| Glass House Brands | 503.27M |
| CytoDyn | 416.55M |
| American Oncology Network | 367.13M |
| Northwest Biotherapeutics | 359.36M |
| Silence Therapeutics | 298.99M |
| Nika Pharmaceuticals | 259.91M |